These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 22077156)

  • 21. Diabetes and bone: biological and environmental factors.
    Piscitelli P; Neglia C; Vigilanza A; Colao A
    Curr Opin Endocrinol Diabetes Obes; 2015 Dec; 22(6):439-45. PubMed ID: 26512769
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of Type 2 Diabetes Mellitus and Antidiabetic Medications on Bone Metabolism.
    Lee HS; Hwang JS
    Curr Diab Rep; 2020 Nov; 20(12):78. PubMed ID: 33247351
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Bone fragility in type 1 diabetes and type 2 diabetes.].
    Fukui T; Takahashi Y
    Clin Calcium; 2019; 29(1):51-56. PubMed ID: 30590360
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Increased fracture rate in patients with type 2 diabetes mellitus is independent of its bone mineral density].
    Yamamoto M; Yamaguchi T; Sugimoto T
    Clin Calcium; 2006 Aug; 16(8):1308-14. PubMed ID: 16883038
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Understanding the pathology and mechanisms of type I diabetic bone loss.
    McCabe LR
    J Cell Biochem; 2007 Dec; 102(6):1343-57. PubMed ID: 17975793
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diabetes and bone fragility: a dangerous liaison.
    Conti F; Wolosinska DT; Pugliese G
    Aging Clin Exp Res; 2013 Oct; 25 Suppl 1():S39-41. PubMed ID: 23907773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of bone quality in patients with diabetes mellitus.
    Jiang N; Xia W
    Osteoporos Int; 2018 Aug; 29(8):1721-1736. PubMed ID: 29736760
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanisms of impaired bone strength in type 1 and 2 diabetes.
    Merlotti D; Gennari L; Dotta F; Lauro D; Nuti R
    Nutr Metab Cardiovasc Dis; 2010 Nov; 20(9):683-90. PubMed ID: 20934862
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of diabetes therapy on bone: A clinical perspective.
    Kheniser KG; Polanco Santos CM; Kashyap SR
    J Diabetes Complications; 2018 Jul; 32(7):713-719. PubMed ID: 29747995
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathophysiology and Management of Type 2 Diabetes Mellitus Bone Fragility.
    Eller-Vainicher C; Cairoli E; Grassi G; Grassi F; Catalano A; Merlotti D; Falchetti A; Gaudio A; Chiodini I; Gennari L
    J Diabetes Res; 2020; 2020():7608964. PubMed ID: 32566682
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathophysiology of Bone Fragility in Patients with Diabetes.
    Palermo A; D'Onofrio L; Buzzetti R; Manfrini S; Napoli N
    Calcif Tissue Int; 2017 Feb; 100(2):122-132. PubMed ID: 28180919
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Usefulness of metformin in diabetes-related bone disease].
    Kanazawa I
    Clin Calcium; 2009 Sep; 19(9):1319-25. PubMed ID: 19721204
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Type 2 diabetes mellitus and bone.
    Compston J
    J Intern Med; 2018 Feb; 283(2):140-153. PubMed ID: 29265670
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bone mineral content and bone density is lower in adolescents with type 1 diabetes: A brief report from the RESISTANT and EMERALD studies.
    Kaur H; Joshee P; Franquemont S; Baumgartner A; Thurston J; Pyle L; Nadeau KJ; Shah VN
    J Diabetes Complications; 2018 Oct; 32(10):931-933. PubMed ID: 29980432
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Diabetes and osteoporosis].
    Valkusz Z
    Orv Hetil; 2011 Jul; 152(29):1161-6. PubMed ID: 21712181
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Type 2 diabetes and the skeleton: new insights into sweet bones.
    Shanbhogue VV; Mitchell DM; Rosen CJ; Bouxsein ML
    Lancet Diabetes Endocrinol; 2016 Feb; 4(2):159-73. PubMed ID: 26365605
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Type 2 Diabetes and Aging: A Not so Sweet Scenario for Bone.
    Dhaliwal R; Rosen CJ
    Horm Metab Res; 2016 Nov; 48(11):771-778. PubMed ID: 27728926
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bone metabolism in diabetes: a clinician's guide to understanding the bone-glucose interplay.
    Sheu A; White CP; Center JR
    Diabetologia; 2024 Aug; 67(8):1493-1506. PubMed ID: 38761257
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Emerging concepts in the pathophysiology of type 2 diabetes mellitus.
    Surampudi PN; John-Kalarickal J; Fonseca VA
    Mt Sinai J Med; 2009 Jun; 76(3):216-26. PubMed ID: 19421965
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Higher levels of s-RANKL and osteoprotegerin in children and adolescents with type 1 diabetes mellitus may indicate increased osteoclast signaling and predisposition to lower bone mass: a multivariate cross-sectional analysis.
    Tsentidis C; Gourgiotis D; Kossiva L; Doulgeraki A; Marmarinos A; Galli-Tsinopoulou A; Karavanaki K
    Osteoporos Int; 2016 Apr; 27(4):1631-1643. PubMed ID: 26588909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.